Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Crinetics Pharmaceuticals Inc shares valued at $781,350 were sold by Pizzuti Dana on Jan 03 ’25. At $52.09 per share, Pizzuti Dana sold 15,000 shares. The insider’s holdings dropped to 29,248 shares worth approximately $1.13 million following the completion of this transaction.
Also, DANA J PIZZUTI purchased 15,000 shares, netting a total of over 781,323 in proceeds.
Before that, Struthers Richard Scott had sold 10,000 shares from its account. In a trade valued at $575,700, the President & CEO traded Crinetics Pharmaceuticals Inc shares for $57.57 each. Upon closing the transaction, the insider’s holdings decreased to 10,000 shares, worth approximately $3.87 million.
As published in a research note from Jefferies on January 22, 2025, Crinetics Pharmaceuticals Inc [CRNX] has been rated up from a Hold to a Buy and the price target has been revised to $55. Analysts at Citigroup started covering the stock with ‘”a Buy”‘ outlook in a report released in early March. As of January 16, 2024, Morgan Stanley has initiated its “an Overweight” rating for CRNX. Earlier on December 21, 2023, Jefferies initiated its rating. Their recommendation was “a Hold” for CRNX stock.
Analyzing CRNX Stock Performance
During the last five days, there has been a surge of approximately 8.51%. Over the course of the year, Crinetics Pharmaceuticals Inc shares have dropped approximately -24.41%. Shares of the company reached a 52-week high of $53.55 on 01/03/25 and a 52-week low of $35.51 on 01/14/25. A 50-day SMA is recorded $52.59, while a 200-day SMA reached $50.80. Nevertheless, trading volume fell to 1.87 million shares from 1.27 million shares the previous day.
Support And Resistance Levels for Crinetics Pharmaceuticals Inc (CRNX)
According to the 24-hour chart, there is a support level at 37.45, which, if violated, would cause prices to drop to 36.25. In the upper region, resistance lies at 40.65. The next price resistance is at 42.65. RSI (Relative Strength Index) is 29.54 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -5.13, which suggests the price will decrease in the coming days. Percent R is at 82.59%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
